Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swen Hesse

Showing results (21-30 of 117) with videos related to

Pageof 12
Sort By:
EJNMMI Reports|September 28, 2025
Advances in clinical neuro-oncology research on integrin PET imagingDylan Henssen, Siem Herings, Osama Sabri, et al.
Journal of Neurosurgery|February 19, 2021
Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's diseaseJulia Löser, Julia Luthardt, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2003
Is correction for age necessary in neuroimaging studies of the central serotonin transporter?Swen Hesse, Henryk Barthel, Toshiya Murai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2022
PET Imaging of Cholinergic Neurotransmission in Neurodegenerative DisordersSolveig Tiepolt, Philipp M Meyer, Marianne Patt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 30, 2012
Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer's disease and healthy volunteersSolveig Tiepolt, Henryk Barthel, Daniel Butzke, et al.
Psychiatry Research|October 11, 2005
Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorderSwen Hesse, Ulrich Müller, Thomas Lincke, et al.
Medicine|June 24, 2016
Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertensionArmin Frille, Karen Geva Steinhoff, Swen Hesse, et al.
Bioelectronic Medicine|February 26, 2025
Long COVID - a critical disruption of cholinergic neurotransmission?Marco Leitzke, Donald Troy Roach, Swen Hesse, et al.
Biological Psychiatry|February 25, 2026
Timing Matters: Leveraging Positron Emission Tomography Imaging and Hormonal Cycles for Precision Psychiatry in Female Mental HealthEmily May, Erika Comasco, Solveig Tiepolt, et al.
Neuropharmacology|April 26, 2016
The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography studyPhilipp Hinderberger, Michael Rullmann, Mandy Drabe, et al.
Pageof 12

Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
EJNMMI Reports|September 28, 2025
Advances in clinical neuro-oncology research on integrin PET imagingDylan Henssen, Siem Herings, Osama Sabri, et al.
Journal of Neurosurgery|February 19, 2021
Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's diseaseJulia Löser, Julia Luthardt, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 22, 2003
Is correction for age necessary in neuroimaging studies of the central serotonin transporter?Swen Hesse, Henryk Barthel, Toshiya Murai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2022
PET Imaging of Cholinergic Neurotransmission in Neurodegenerative DisordersSolveig Tiepolt, Philipp M Meyer, Marianne Patt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 30, 2012
Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer's disease and healthy volunteersSolveig Tiepolt, Henryk Barthel, Daniel Butzke, et al.
Psychiatry Research|October 11, 2005
Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorderSwen Hesse, Ulrich Müller, Thomas Lincke, et al.
Medicine|June 24, 2016
Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertensionArmin Frille, Karen Geva Steinhoff, Swen Hesse, et al.
Bioelectronic Medicine|February 26, 2025
Long COVID - a critical disruption of cholinergic neurotransmission?Marco Leitzke, Donald Troy Roach, Swen Hesse, et al.
Biological Psychiatry|February 25, 2026
Timing Matters: Leveraging Positron Emission Tomography Imaging and Hormonal Cycles for Precision Psychiatry in Female Mental HealthEmily May, Erika Comasco, Solveig Tiepolt, et al.
Neuropharmacology|April 26, 2016
The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography studyPhilipp Hinderberger, Michael Rullmann, Mandy Drabe, et al.
Pageof 12